Skip to content Skip to sidebar Skip to footer
Menu
Menu
Newsletter
Menu
Newsletter
PointsBet
Tech Stocks Technology
PointsBet (ASX: PBH) is attempting a turnaround and the market is starting to believe it
PointsBet (ASX: PBH) has spent the past two years unwinding one of the more damaging expansion strategies in the ASX small-cap universe. The push into the United States burned capital, eroded confidence and ultimately forced a full strategic reset. That reset is now largely complete. What matters is what happens next. The share price is beginning…
April 14, 20260Comments
Telix Pharmaceuticals
Healthcare Stocks
Telix Pharmaceuticals (ASX:TLX) Regeneron $14b revenue partner, 49m shorts face pressure
$40m Regeneron cheque validates RLS as 49m shorts watch Telix Pharmaceuticals (ASX:TLX) is building momentum after the positive NDA update for Pixclara, its PET imaging agent for glioma, a form of brain cancer. Today, the company added to that momentum by announcing a 50/50 partnership with Regeneron to develop and commercialise a new generation of…
April 13, 20260Comments
ASX
Tech Stocks Technology
AMA Group (ASX:AMA) recovery is now being tested by whether cash flow can sustain the turnaround
AMA Group (ASX: AMA)’s recovery story is now being tested by whether improving earnings can translate into durable cash flow across its collision repair network, rather than fading as a short-term rebound. The business has moved beyond a pure survival narrative, but operating risks in parts of the network and still-soft repair volumes mean the…
April 10, 20260Comments
Atomo Diagnostics
Healthcare Stocks
Radiopharm Theranostics (ASX: RAD) is increasingly defined by whether RAD101 can justify a registrational pathway
Radiopharm Theranostics (ASX:RAD) is increasingly defined by whether its lead imaging asset RAD101 can convert encouraging mid-stage data into a credible registrational pathway, against a backdrop where clinical and execution risk remains high. The company has assembled a broad oncology radiopharmaceutical pipeline, but its near-term valuation still centres on whether one program can move from…
April 10, 20260Comments
PEXA
Tech Stocks Technology
3P Learning (ASX:3PL) must arrest school churn to protect its valuation
3P Learning (ASX: 3PL)’s valuation now hinges on whether the business review can arrest B2B school churn and declining revenue before the longer-term value in Reading Eggs, Mathletics and its expanding US homeschool channel is eroded. The urgency is clear from the half-year result: revenue fell to $51.9m and underlying EBITDAA to $5.7m, prompting management…
April 10, 20260Comments
iperionx
Tech Stocks Technology
IperionX (ASX: IPX) needs repeat Virginia orders to unlock its titanium platform value
IperionX (ASX: IPX) is now a trade-off between the cash-hungry ramp-up at its Virginia Titanium Manufacturing Campus and the longer-term value of a government-backed domestic titanium platform that already has funding, feedstock and a permitted upstream asset in Titan. With Virginia online at 200tpa and expanding toward 1,400tpa, the company has moved beyond technology claims…
April 10, 20260Comments

Independent ASX research and stock analysis. Actionable investment ideas on ASX-listed stocks from analysts who call it straight.

Sectors
Quick Links
Learn

Stocks Down Under (Pitt Street Research AFSL 1265112) provides actionable investment ideas on ASX-listed stocks. This content provides general information only and does not constitute financial advice. Always do your own research before making investment decisions. © 2026 Stock Down Under. All Rights Reserved.

the Kick-ass Multipurpose WordPress Theme

Investing in the Year of the Rat
2020, the Golden Year
Market trouble spots to avoid in 2020
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here